From Chicago, at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy
A daily regimen of the antiviral drug valacyclovir controls genital herpes vastly better than does the same medication when used only to treat outbreaks of the disease, according to a new study.
To compare the effectiveness of the two approaches, scientists identified 66 people who averaged four to nine genital herpes recurrences per year.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.